Prevention and therapy of hepatocellular carcinoma by vaccination with TM4SF5 epitope-CpG-DNA-liposome complex without carriers
about
Immunization with a hemagglutinin-derived synthetic peptide formulated with a CpG-DNA-liposome complex induced protection against lethal influenza virus infection in mice.Therapeutic effect of a TM4SF5-specific peptide vaccine against colon cancer in a mouse modelTherapeutic effect of a TM4SF5-specific monoclonal antibody against colon cancer in a mouse model.TM4SF4 overexpression in radiation-resistant lung carcinoma cells activates IGF1R via elevation of IGF1.Extracellular Release of CD11b by TLR9 Stimulation in MacrophagesProduction of epitope-specific antibodies using peptide-CpG-ODN-liposome complex without carriers and their application as a cancer vaccine in mice.A monoclonal antibody against the human SUMO-1 protein obtained by immunization with recombinant protein and CpG-DNA-liposome complex.Anti-metastatic effect of the TM4SF5-specific peptide vaccine and humanized monoclonal antibody on colon cancer in a mouse lung metastasis model.Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility.Promising new strategies for hepatocellular carcinoma.Adenovirus-mediated delivery of siRNA targeting TM4SF4 attenuated liver cancer cell growth in vitro and in vivo.CpG oligodeoxynucleotides enhance chemosensitivity of 5-fluorouracil in HepG2 human hepatoma cells via downregulation of the antiapoptotic factors survivin and livin.CpG-DNA exerts antibacterial effects by protecting immune cells and producing bacteria-reactive antibodies
P2860
Q30423481-27377589-1024-41E0-8AA8-4F6EBB248AFDQ34180043-68E937C7-B93F-4EA2-88DA-F26AE260EFCFQ34483608-EE1E674D-A61A-45D1-950E-B9C22FA3E202Q34654685-7F497F37-FB4D-420D-B493-96EAFB2E3BC5Q35949203-E2B188B8-9C20-4E34-830F-E29B477455DCQ36388576-6B243DBC-1ACB-4212-871C-307BCB17476BQ37233554-D6F021CD-8ACF-4460-AFF0-1D010EB51CB8Q37694769-CAB97763-058B-4173-8B90-A236C25CE43DQ38450711-9FE9DE76-7E93-449E-B53C-7D56A41B2C8EQ38936589-740D6E1D-986C-410B-BFEE-3923654571CDQ39215010-9155B8E0-6210-415B-86DE-200CDD93CD24Q41885916-3DC7DB58-1C6A-4C2A-B0E1-D68A7BED96CFQ58618165-1728DB69-E0B5-4CB8-92F4-3D0B93F1F2B7
P2860
Prevention and therapy of hepatocellular carcinoma by vaccination with TM4SF5 epitope-CpG-DNA-liposome complex without carriers
description
2012 nî lūn-bûn
@nan
2012 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մարտին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Prevention and therapy of hepa ...... osome complex without carriers
@ast
Prevention and therapy of hepa ...... osome complex without carriers
@en
Prevention and therapy of hepa ...... osome complex without carriers
@nl
type
label
Prevention and therapy of hepa ...... osome complex without carriers
@ast
Prevention and therapy of hepa ...... osome complex without carriers
@en
Prevention and therapy of hepa ...... osome complex without carriers
@nl
prefLabel
Prevention and therapy of hepa ...... osome complex without carriers
@ast
Prevention and therapy of hepa ...... osome complex without carriers
@en
Prevention and therapy of hepa ...... osome complex without carriers
@nl
P2093
P2860
P1433
P1476
Prevention and therapy of hepa ...... osome complex without carriers
@en
P2093
Byoung Kwon Park
Cheung-Seog Park
Dongbum Kim
Doo-Sik Kim
Hyun-Jong Ahn
Hyung-Joo Kwon
Jae-Nam Seo
Kwang Dong Kim
Kyung-Chan Choi
Sanghoon Kwon
P2860
P304
P356
10.1371/JOURNAL.PONE.0033121
P407
P577
2012-03-12T00:00:00Z